BE536229A - - Google Patents
Info
- Publication number
- BE536229A BE536229A BE536229DA BE536229A BE 536229 A BE536229 A BE 536229A BE 536229D A BE536229D A BE 536229DA BE 536229 A BE536229 A BE 536229A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- xanthocillin
- product
- compounds
- tyrothricin
- Prior art date
Links
- 239000000047 product Substances 0.000 claims description 24
- YBMVKDUTYAGKEW-WHYMJUELSA-N 4-[(1z,3z)-4-(4-hydroxyphenyl)-2,3-diisocyanobuta-1,3-dienyl]phenol Chemical compound C1=CC(O)=CC=C1\C=C(/[N+]#[C-])\C(\[N+]#[C-])=C\C1=CC=C(O)C=C1 YBMVKDUTYAGKEW-WHYMJUELSA-N 0.000 claims description 14
- GSXRBRIWJGAPDU-BBVRJQLQSA-N tyrocidine A Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)=O)CC(C)C)C(C)C)C1=CC=C(O)C=C1 GSXRBRIWJGAPDU-BBVRJQLQSA-N 0.000 claims description 11
- 108010021006 Tyrothricin Proteins 0.000 claims description 10
- 229930187731 Xanthocillin Natural products 0.000 claims description 10
- 229960003281 tyrothricin Drugs 0.000 claims description 10
- 239000000645 desinfectant Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 239000011149 active material Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010026389 Gramicidin Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960004905 gramicidin Drugs 0.000 description 2
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 244000000058 gram-negative pathogen Species 0.000 description 1
- 244000000059 gram-positive pathogen Species 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE536229A true BE536229A (d) |
Family
ID=166990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE536229D BE536229A (d) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE536229A (d) |
-
0
- BE BE536229D patent/BE536229A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0078785B1 (fr) | Sels d'acide valproîque, leur préparation et leur utilisation | |
| FR2757520A1 (fr) | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent | |
| CA2146765A1 (fr) | Nouveaux derives du taxane, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| BE536229A (d) | ||
| BE466916A (d) | ||
| EP0092287B1 (fr) | Sels d'acétylcystéine, leur préparation et leur utilisation | |
| LU85292A1 (fr) | Procede pour la preparation de 1,8-dihydroxy-10-acyl-9-anthrones,en particulier pour une utilisation dans le traitement du psoriasis | |
| EP0539460A1 (fr) | Sels derives de la dialcoylaminoalcoylsulfonyl-26 pristinamycine ii b. | |
| CA2376025C (fr) | Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme antifongiques | |
| FR2470765A1 (fr) | Nouveaux sels d'addition d'acides du 4'-(9-acridinyl-amino)methanesulf-m-anisidide, leur procede de production et composition pharmaceutique les contenant | |
| BE887220A (fr) | Compositions antitumeurs | |
| LU84421A1 (fr) | Sels d'acide ursodesoxycholique,leur preparation et leur utilisation | |
| BE482618A (d) | ||
| CH286676A (fr) | Procédé de préparation de la procäine-pénicilline. | |
| CH406194A (fr) | Procédé de préparation de sels stables de diméthylcarboxy-alkylsulfonium | |
| BE636975A (d) | ||
| BE641473A (d) | ||
| CH394234A (fr) | Procédé de préparation du chlorure de la carnitine | |
| BE519389A (d) | ||
| CH320196A (fr) | Procédé de préparation du sel calcique pratiquement pur de la chlortétracycline | |
| EP0066934A1 (fr) | Sels de nitrofurantoine, leur préparation et leur utilisation | |
| CH334135A (fr) | Procédé de préparation de sulfate de chlortétracycline pratiquement pur | |
| CH394488A (fr) | Procédé de préparation d'antigènes cellulaires | |
| BE470863A (d) | ||
| CH246130A (fr) | Procédé pour la préparation de substances antibactérielles à partir de ferments. |